Literature DB >> 29387225

MicroRNA-26b-5p regulates cell proliferation, invasion and metastasis in human intrahepatic cholangiocarcinoma by targeting S100A7.

Fei Fan1, Jiongjiong Lu1, Wenlong Yu2, Yongjie Zhang2, Suqian Xu1, Leilei Pang3, Bin Zhu1.   

Abstract

The present study aimed to investigate the effects of microRNA expression in intrahepatic cholangiocarcinoma (ICC). It was identified that the expression of microRNA-26b-5p (miR-26b-5p) was downregulated in ICC tissues compared with matched adjacent non-tumor tissues. Furthermore, miR-26b-5p expression was downregulated in metastatic ICC tumor tissues and invasive ICC cell line subpopulations compared with non-metastatic tumor tissue and the parental ICC cells. In vitro studies demonstrated that transfection with an miR-26b-5p mimic inhibited the proliferation, migration and invasion of RBE and HCCC-9810 cells, whereas an miR-26b-5p inhibitor promoted these abilities. S100 calcium-binding protein A7 (S100A7) was predicted as a direct target of miR-26b-5p. Transfection with an miR-26b-5p mimic decreased S100A7 expression, whereas an miR-26b-5p inhibitor increased S100A7 expression. The result of a dual luciferase reporter assay also indicated this interaction. S100A7 was therefore confirmed as a direct target of miR-26b-5p in ICC. The knockdown of S100A7 abrogated the effect of miR-26b-5p on cell migration in RBE and HCCC-9810 cells. In conclusion, the present study demonstrated that miR-26b-5p suppresses the proliferation, migration and invasion of ICC cells by suppressing S100A7.

Entities:  

Keywords:  S100 calcium-binding protein A7; intrahepatic cholangiocarcinoma; invasion; microRNA-26b-5p; migration; proliferation

Year:  2017        PMID: 29387225      PMCID: PMC5768070          DOI: 10.3892/ol.2017.7331

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  25 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 3.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

Review 4.  Multidisciplinary approaches to intrahepatic cholangiocarcinoma.

Authors:  Shishir K Maithel; T Clark Gamblin; Ihab Kamel; Celia Pamela Corona-Villalobos; Melanie Thomas; Timothy M Pawlik
Journal:  Cancer       Date:  2013-08-20       Impact factor: 6.860

Review 5.  Epigenetic regulation of microRNAs in cancer: an integrated review of literature.

Authors:  Tanja Kunej; Irena Godnic; Jana Ferdin; Simon Horvat; Peter Dovc; George Adrian Calin
Journal:  Mutat Res       Date:  2011-03-21       Impact factor: 2.433

6.  Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia.

Authors:  Deepa Sampath; Chaomei Liu; Karthik Vasan; Melanie Sulda; Vinay K Puduvalli; William G Wierda; Michael J Keating
Journal:  Blood       Date:  2011-11-16       Impact factor: 22.113

7.  Recurrence after operative management of intrahepatic cholangiocarcinoma.

Authors:  Omar Hyder; Ioannis Hatzaras; Georgios C Sotiropoulos; Andreas Paul; Sorin Alexandrescu; Hugo Marques; Carlo Pulitano; Eduardo Barroso; Bryan M Clary; Luca Aldrighetti; Cristina R Ferrone; Andrew X Zhu; Todd W Bauer; Dustin M Walters; Ryan Groeschl; T Clark Gamblin; J Wallis Marsh; Kevin T Nguyen; Ryan Turley; Irinel Popescu; Catherine Hubert; Stephanie Meyer; Michael A Choti; Jean-Francois Gigot; Gilles Mentha; Timothy M Pawlik
Journal:  Surgery       Date:  2013-03-15       Impact factor: 3.982

Review 8.  RNA and transcriptional modulation of gene expression.

Authors:  Peter G Hawkins; Kevin V Morris
Journal:  Cell Cycle       Date:  2007-12-29       Impact factor: 4.534

9.  In-depth characterization of microRNA transcriptome in melanoma.

Authors:  James Kozubek; Zhihai Ma; Elizabeth Fleming; Tatiana Duggan; Rong Wu; Dong-Guk Shin; Soheil S Dadras
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

10.  The atypical mechanosensitive microRNA-712 derived from pre-ribosomal RNA induces endothelial inflammation and atherosclerosis.

Authors:  Dong Ju Son; Sandeep Kumar; Wakako Takabe; Chan Woo Kim; Chih-Wen Ni; Noah Alberts-Grill; In-Hwan Jang; Sangok Kim; Wankyu Kim; Sang Won Kang; Andrew H Baker; Jai Woong Seo; Katherine W Ferrara; Hanjoong Jo
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  6 in total

1.  Identification and Interaction Analysis of Key Genes and MicroRNAs in Systemic Sclerosis by Bioinformatics Approaches.

Authors:  Yan-Hong Sun; Meng Xie; Shi-di Wu; Jing Zhang; Chang-Zheng Huang
Journal:  Curr Med Sci       Date:  2019-07-25

Review 2.  Friend or Foe: S100 Proteins in Cancer.

Authors:  Chantal Allgöwer; Anna-Laura Kretz; Silvia von Karstedt; Mathias Wittau; Doris Henne-Bruns; Johannes Lemke
Journal:  Cancers (Basel)       Date:  2020-07-24       Impact factor: 6.639

3.  Aspirin inhibits cholangiocarcinoma cell proliferation via cell cycle arrest in vitro and in vivo.

Authors:  Tingting Shi; Jian Gong; Koji Fujita; Noriko Nishiyama; Hisakazu Iwama; Shi Liu; Mai Nakahara; Hirohito Yoneyama; Asahiro Morishita; Takako Nonura; Hideki Kobara; Keiichi Okano; Yasuyuki Suzuki; Tsutomu Masaki
Journal:  Int J Oncol       Date:  2020-12-30       Impact factor: 5.650

Review 4.  The Interaction Between Non-Coding RNAs and Calcium Binding Proteins.

Authors:  Soudeh Ghafouri-Fard; Jamal Majidpoor; Hamed Shoorei; Bashdar Mahmud Hussen; Hazha Hadayat Jamal; Aria Baniahmad; Mohammad Taheri; Majid Mokhtari
Journal:  Front Oncol       Date:  2022-03-04       Impact factor: 6.244

Review 5.  S100 Proteins as Novel Therapeutic Targets in Psoriasis and Other Autoimmune Diseases.

Authors:  Katarzyna Kurpet; Grażyna Chwatko
Journal:  Molecules       Date:  2022-10-06       Impact factor: 4.927

6.  Identification of MMP9 as a novel key gene in mantle cell lymphoma based on bioinformatic analysis and design of cyclic peptides as MMP9 inhibitors based on molecular docking.

Authors:  Wei Yan; Shawn Xiang Li; Minjie Wei; Hua Gao
Journal:  Oncol Rep       Date:  2018-09-05       Impact factor: 3.906

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.